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1. Introduction 
The development of affinity labels for the muscarinic 
acetylcholine receptor [l-4] has opened the way for 
studies on the binding of agonists (activators) with this 
receptor, using the inhibition of the binding of the af- 
finity label as a measure of the binding of the agonist. 
There are, however, difficulties in this approach, since 
it is necessary to have the agonists present in concen- 
trations far greater than those necessary to obtain a con- 
tractile response and also for extened period of time, 
conditions which lead to receptor desensitisation (see 
e.g. ref. [5]). In intact longitudinal muscle strips from 
the guinea-pig small intestine, as described here, and in 
microsomal fractions from homogenates of this tissue 
[6] , the binding of agonists shows an apparent negative 
co-operativity (Hill coefficients approx. OA-0.5), while 
the binding curves for antagonists have, within experi- 
mental error, the slope predicted (Hill coefficient = l), 
from a simple mass-action equilibrium. In this commu- 
nication it is shown that the slope of the Hill plot for the 
binding of carbachol to intact muscle strips can be in- 
creased to approximately unity, with an increase in the 
concentration of carbachol required for half-maximal 
inhibition of the binding of the affinity label, tritiated 
propylbenzilylcholine mustard (3H-PrBCM)*, if the tis- 
sue is exposed to a desensitizing dose of the agonist im- 
mediately prior to the labelling. 
* Abbreviation: ’ HPrBCM, N-2’-chloroethyl-N-[ 2”, 3”-‘H, ] 
propyl-Zaminoethyl benzilate. 
2. Methods 
Strips of the longitudinal muscle of guinea-pig small 
intestine [7] were suspended in Krebs-Henseleit solu- 
tion gassed with 95% 02-5% COZ at 30°C and prein- 
cubated for 1 hr. 3 H-PrBCM (final concentration of 
aziridinium ion 2.4 X lOmy M) was then added and 4 or 
10 min later the reaction terminated by transferring the 
strips to fresh Krebs and washing for a further 75 min 
with three further changes of the medium. Where appro- 
priate receptor antagonists were added 30 min before, 
and agonists 30 set or 1 min before the 3H-PrBCM. The 
strips were blotted dry, weighed and bound tritium de- 
termined by liquid scintillation counting after solubili- 
sation of the tissue. A more detailed description of the 
procedure has been given elsewhere [2]. 
The 3 H-PrBCM, specific activity 1.4 Ci/mmol or 1.8 
Ci/mmol [2] , was always converted into the aziridinium 
ion derivative, the pharmacologically active form [l] , 
prior to addition to the medium by incubation in 10 mM 
phosphate buffer, pH 7.5, at room temperature for 1 
hr [2]. 
Propylbenzilylcholine (N,iV-dimethyl-N-propyl-2- 
aminoethyl benzilate) was kindly synthesised for us by 
Mr B. Peck, following the method of Ford-Moore and 
Ing PI. 
3. Results and discussion 
Approximately 85% of the binding of 3 H-PrBCM by 
longitudinal muscle strips could be inhibited by musca- 
rinic agonists or antagonists. However, while antagonists 
yielded binding curves with a Hill slope not significantly 
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Table 1 
Slopes of Hill plots for the inhibition by muscarinic agonists 
and antagonists of the binding of ’ H-PrBCM 
Antagonists 
Atropine 
Methylatropinium 
Propylbenzilylcholine 
0.84 + 0.06 (6) 
0.95 * 0.14 (11) 
0.96 + 0.14 (4) 
Agonists 
zI20- 
al 
:z 100 - 
.E 
5 80- 
B 
$fi 60. 
? 
2 LO- 
: 20. 
c 0 
I 0 
Acetylcholine* 
Carbachol 
Hexyltrimethylammonium 
(+)-Acetyl-p-methacholine? 
0.54 f 0.06 (6) 
0.44 f 0.08 (9) 
0.51 f 0.10 (9) 
0.36 * 0.06 (9) 
0’ 10-8 10-6 10-L 10-2 
Karbochol] (M) 
The values are the slopes * standard error, with the number of 
points in parenthesis, of plots of log [(lOO-% of uninhibited 
binding of ’ H-PrBCM) / (% of uninhibited binding - % non- 
specific binding)] vs Log [inhibitor]. Antagonists were added 
30 min before, and agonists 1 min before the ‘H-PrBCM. In- 
cubation with ‘H-PrBCM (2.4 nM) was for 10 min at 30°C. 
For all inhibitors the non-specific binding was taken as 15%. 
* In the presence of 10.’ M neostigmine. 
t In the presence of 10r6 M physostigmine. 
Fig. 1. Inhibition by carbachol or ’ H-PrBCM binding by muscle 
strips with (0) or without (*) prior desensitisation. Incubation 
with ’ H-PrBCM (2.4 nM) was for 4 min at 30°C. The points are 
values of the ratio 100 X ‘H-PrBCM bound in presence of inhi- 
bitor / ‘H-PrBCM bound in absence of inhibitor (15-22 strips 
for each point) with the approx. 69% confidence limits (vertical 
bars). For prior desensitisation (0) the strips were exposed to 
10.’ M carbachol for 15 min then washed for 15 set in Krebs- 
Henseleit solution containing the concentration of carbachol to 
be tested (zero for total binding) before transfer to Krebs- 
Henseleit solution containing ‘HPrBCM with or without car- 
bachol. 
different from unity (table l), as predicted by a simple Hill slope 0.40 f 0.04) but the curve was shifted to the 
mass-action equilibrium, all the agonists tested yielded left. This suggested that the apparent negative co-opera- 
curves with mean Hill slopes around 0.5, all being signi- tivity might be a consequence of receptor desensitisation, 
ficantly different from unity. Similar observations have the rate of which is well known to be dependent on the 
been made by Burgen and Hiley [6] for the binding of concentration of agonist present and the time for which 
acetylcholine to a microsomal fraction derived from an it acts, the implication being that desensitisation involves 
homogenate of this tissue. The period of exposure to a change in receptor conformation with a decreased af- 
3H-PrBCM, which forms a covalent bond with the recep- finity for the agonist. Recovery from desensitisation, as 
tor, was kept as short as experimentally convenient since measured by the recovery of the contactile response to 
ultimately the binding of the irreversible label will over- an agonist is slow, although determination of the.true 
come the inhibition by the reversible antagonist, giving rate of receptor recovery is complicated by the fact that 
too low a value for the inhibition (see ref. [9] for a dis- in smooth muscle there is also a non-specific component 
cussion). However the rate of 3H-PrBCM binding by the to desensitisation [lo] . Taking advantage of the slow 
intact muscle strips is such that during the 10 min expo- recovery, muscle strips were exposed to 10m4 M carba- 
sure employed in the experiments in table 1 only some chol for 15 min and then washed for 15 set before label- 
16% of the total number of receptors available are occu- ling with 3 H-PrBCM for 4 min in the presence or absence 
pied [2] and under these conditions the reduction in the of carbachol. The prior desensitisation led to only a small 
binding in the presence of an inhibitor should give a good and statistically non-significant decrease in the binding 
measure of the true inhibition. Consistent with this reduc- of ’ H-PrBCM (12% and 12%, 2 experiments). However 
ing the period of exposure to 3 H-PrBCM form 10 to 4 min the inhibition curve for carbochol (fig. 1 open points) 
did not significantly after either the shape or the position was both steeper (Hill coefficient 0.90 + 0.2 1) and also 
of the percentage inhibition us concentration curve for shifted to the right. This suggests that, as with the nico- 
atropine. The shape of the inhibition curve for carbachol tinic acetylcholine receptor in chick biventer muscle [ 1 l] , 
(fig. 1, filled points) was not significantly altered (mean the phenomenon of desensitisation of muscarinic acetyl- 
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choline receptors in the longitudinal muscle from guinea- 
pig small intestine is associated with a change in receptor 
conformation. It demonstrates in addition that this re- 
sults in a decrease in the binding affinity for an agonist, 
carbachol (approx. lo4 M-’ for the desensitised recep- 
tor). Further it seems probable that the Hill coefficients 
of approx. 0.4-0.5 observed for inhibition of 3H-PrBCM 
binding vs concentration curves for agonists when there 
is no pretreatment with agonist reflects the increasing 
degree of desensitisation occurring during the course 
of the incubation as the concentration of agonist used 
as inhibitor is increased. This proposition is lent some 
support by the contrast with the inhibition by an ago- 
nist, decamethonium, of the binding of the a-toxin 
from Nzja nigricollis by membrane fragments from the 
electroplax of Electrophoms electricus [ 121, a tissue 
which apparently does not show the phenomenon of 
desensitisation [ 131 . There the binding curve obtain- 
ed for decamethonium approximated well to a rectan- 
gular hyperbola (Hill coefficient = 1) for most of its 
length and varying the time of preincubation with the 
agonist was without effect on the level of inhibition 
observed [ 121. 
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